Objective. RA accelerates bone loss, increasing the risk of osteoporosis (OP) and fracture. DXA imaging has been validated for identifying RA patients at risk of fracture. The objective of this study was to assess the presence of asymptomatic vertebral fractures (VFs) in a cohort of patients with established RA referred for DXA using VF assessment (VFA) technology.
Introduction
RA is a chronic, systemic, inflammatory disease associated with persistent synovitis, progressive joint destruction and an excess mortality when compared with the general population [1] . Osteoporosis (OP) is well recognized as the main extra-articular complication of RA and results in an increased risk of fractures [2, 3] . This gradient of risk is similar to that of cardiovascular disease [2, 68] , which persists after adjustment for BMD, glucocorticoid use and prior fracture [2, 48] . Longitudinal studies in RA patients have shown systemic bone loss of up to 10% in early disease [2] and a more than 2-fold increased relative risk for hip and pelvic fractures [48] .
The underlying mechanism for OP in RA patients is multifactorial. Some studies have suggested the association between OP and proinflammatory cytokines such as TNF-a, IL-1 and IL-6 [9], while others have implicated higher disease activity as an independent risk [10] . Other factors include glucocorticoid use, low BMI, menopausal status and physical inactivity [2] . Low BMD is another important risk factor for fracture. However, there is a discrepancy between low BMD and fracture risk, as a number of fractures are observed in patients with T-scores that are not in the osteoporotic range [5] .
The risk of vertebral fractures (VFs) is also higher in patients with RA than in those with primary OP [47] . There is at least a 2-fold increased risk of VFs in RA, and a greater risk, up to 6-fold, has been reported in patients with long-standing disease [5, 8] . Prior VFs are associated with a 4-to 5-fold increased risk of future spine fractures [11] and a 1.5-fold increased risk of future hip fractures [12] , independent of BMD. The consequences of VFs, even ones that have not been recognized clinically, and back-related disability can have a strong impact on these patients with an underlying disability related to RA [2] . The mortality rate 5 years after a clinical VF is 20% greater than expected and increases with the number of VFs [13] .
National and international guidelines recommend measurement of BMD by central DXA in many RA patients because their disease or treatment can result in rapid bone loss and increased propensity to fracture [1417] . Although only 2030% of VFs are recognized either clinically [18] or discovered incidentally on radiographs, technological advances in image acquisition also enable detection of prevalent VFs using VF assessment (VFA) modalities at the time of DXA scanning [1920] , an assessment recommended for at-risk persons, including those on glucocorticoids or with RA [20, 21] . Despite the high prevalence of OP and VFs in RA, we could only find four studies addressing VFs using VFA technology in postmenopausal RA women [2124] . However, no data exist on the frequency of VFs on VFA imaging in a large representative sample of RA men and women, emphasizing the need for such data. Therefore we undertook a crosssectional study the aim of determining the prevalence and severity of VFs on DXA VFA imaging in a cohort of RA patients. We also evaluated factors independently associated with VF in this population.
Materials and methods

Study population
We conducted a cross-sectional study of a convenience cohort of subjects with RA at our university hospital between October 2011 and May 2012. Eligible subjects included all patients of age 540 years who met the ACR classification criteria for RA [25] and had a DXA and VFA scan available for analysis. Patients' medical records were reviewed to document medications and to confirm the diagnosis of RA. Demographics were obtained from their medical records and cross-checked with their DXA scan record. The study was approved by the Galway University Hospitals Institutional Review Board; informed consent was waived by the institutional review board. We excluded subjects with incomplete or missing medical records and those with missing DXA and/or VFA images.
Study protocol
Detailed data were collected on all subjects, including baseline demographics such as age, gender, ethnicity, smoking status, body height, weight and BMI (kg/m 2 );
RA clinical characteristics such as disease duration, extra-articular features, RF and ACPA status, CRP and the Westergren ESR; baseline cardiovascular risk factors including tobacco smoking, diabetes mellitus, hypercholesterolaemia and hypertension and medication use. For the purpose of the study, we defined glucocorticoid use as RA subjects who were using 55 mg/day of glucocorticoids for >3 months and non-users as those who appeared to have never used glucocorticoids or only one or two brief courses. RA activity was quantified by modified HAQ and 28-joint count DAS (DAS28) [26, 27] . All the data were obtained by double-data entry by one reviewer (A.M.) excluding patient identifiers.
Assessment of VFs
All DXA scans were performed using one of two DXA [28] . Briefly, each of the vertebrae from T4 to L4 was first evaluated for image quality. We considered vertebrae whose superior and inferior end plates could be seen from the posterior to anterior borders of the vertebra suitable for evaluation. Those evaluable vertebrae were graded for deformity as per the criteria [28] . Briefly, vertebrae were judged to be normal (grade 0) or fractured. These fractures were graded 1, 2 or 3 (mild, moderate or severe) when vertebral height (anterior, middle or posterior) appeared reduced by 2025%, >25<40%, or 540%, respectively. Patients with at least one grade 1 fracture were considered as fractured. For the purposes of the study, patients were diagnosed as normal, osteopenia or OP using the World Health Organization (WHO) DXA criteria.
Statistical analyses
Baseline characteristics among patients with RA are expressed in mean (S.D.) or median [interquartile range (IQR)] for continuous variables and proportions for categorical variables. The data were stratified by the presence of VF. Comparisons between groups were performed by the independent samples t-test for continuous data, and Pearson chi-square test for categorical data. Correlation of BMD and VF with different variables was performed using Spearman's rank correlation test. The inter-observer agreement for the presence of VF was measured using a weighted kappa coefficient. We compared the prevalence of OP and VF between RA patients. The 95% CIs were computed for differences between means and odds ratios (ORs) for paired data. Multivariate stepwise regression analysis was used to estimate the independent effects of RA-related clinical and laboratory variables on OP and VFs. These analyses were adjusted for traditional risk factors, including age, gender, smoking, hypercholesterolaemia, BMI, hypertension and diabetes mellitus. Statistical significance was determined using a two-sided 5% significance level (i.e. P-value < 0.05). All statistical analyses were performed using the PASW Statistics for Windows (version 18.0; SPSS, Chicago, IL, USA).
Results
Patient characteristics
A total of 1330 patients attending our rheumatology service with inflammatory arthritis listed as definite or probable RA were screened for study eligibility. Six hundred and three met the study inclusion criteria. The majority of patients with RA were female (71%), the mean duration of RA disease was 15 years and 76% were seropositive. In our population, 94% were treated with non-biologic DMARDs, 43% with biological agents and 43% with glucocorticoids. The demographic and clinical characteristics of the study population are shown in Table 1 .
Prevalence of VFs
One hundred and nine VFs were identified in 77 of the 603 (13%) RA subjects: 56 patients had only one VF and 21 had two or more fractures detected on VFA imaging. The clinical features and RA-specific characteristics of subjects with and without VFs are outlined in Table 1 . The majority of patients with VFs were female (58%) whose mean age was 56 (S.D. 11.8) years, and 34% were <50 years of age. The prevalence of OP was significantly higher in those with VFs (58% vs 28%) when compared with those without, and 40% of the subjects with fractures had a BMD in the range of osteopenia on DXA (Table 1) . were more common in the lumbar spine as compared with the thoracic spine (68% vs 32%). Inter-observer agreement for the presence of VFs was strong, with a weighted kappa coefficient of 0.92. Table 3 shows the number of RA patients in categories of age, gender and BMD that were deemed to have one or more VF. In comparison with subjects <50 years of age, VFs were detected in a significantly higher proportion of those age 550 years (65% vs 35%, P < 0.001), where a significant proportion had OP on DXA (78% vs 22%, P < 0.001). The prevalence and severity of VFs showed significant correlation with lumbar spine T-scores (r = À0.37, P < 0.001), femoral T-scores (r = À0.31, P < 0.001), CRP (r = 0.724, P < 0.001) and DAS28 (r = 0.789, P < 0.05).
Risk factors for VFs
VFs were observed more frequently in females, those who had a longer duration of RA and those with higher measures of disease activity. The frequency of NSAID use and glucocorticoid use was similar between subjects with and without VFs. Overall use of DMARDs was similar between both groups. Among traditional risk factors, subjects with VF tended to be older and were more likely to have hypercholesterolaemia. The clinical features and RA-specific characteristics of subjects with and without VFs are outlined in Table 1 .
In multivariate stepwise regression analyses adjusted for traditional risk factors (these risk factors are retained from the comparative analysis- Table 1 ), including age, gender, BMI, smoking status, hypercholesterolaemia, hypertension and the presence of diabetes mellitus, a significant association was noted between VF and RAspecific features such as longer duration of the disease, ACPA and elevated markers of disease activity, while there was no significant association with RF antibodies and medications for RA, including glucocorticoids, NSAIDs and DMARDs (Table 4) .
Discussion
In this study, VFA imaging identified vertebral deformities consistent with fracture in 13% of asymptomatic RA patients referred for bone densitometry, and 83% (64/ 77) of these had vertebral deformities of grade 2 or 3. This is in contrast to prior studies that reported a higher prevalence of VFs ranging from 22 to 36% among patients with RA [2124] . However, these studies evaluated the prevalence of VFs in RA women only, some of whom had a previous history of non-VFs [24] . We investigated a heterogeneous RA population composed of men and women of different ages who had no prior history of fracture. These disparities in the populations studied may account for the differences in the observed results. However, our study results appear to be consistent with prevalence studies in the general population [13, 29] .
In our cohort, 34% of those with VFs were <50 years of age, and the majority of these had osteopenia by BMD criteria. These results are not surprising, as a BMD reduction of 5.5% in the lumbar spine and 8.7% in the femoral neck, along with osteoporotic fractures in RA populations <50 years of age have been well described [8, 30, 31] .
Contrary to the published literature on VFs in RA [2124], fractures were more common in the lumbar region in our study. Although the reasons for this are unclear, it is possibly related to chronic systemic inflammation, which is consistently associated with systemic bone loss [37] . However, a reasonable question is whether or not these individuals should have standard lateral spine radiographs to look for vertebral deformities that may have been missed on VFA films. Standard radiographs Normal: T-score greater than À1.0 at the lumbar spine, total hip and femoral neck; osteopenia: T-score between À1.0 and À2.4 at the lumbar spine, total hip or femoral neck, but greater than À2.5 at all three; OP: T-score À2.5 or less at the lumbar spine, total hip or femoral neck. Wedge  25  50  12  87  Biconcave  7  9  3  19  Crush  2  1  0  3  Total  34  60  15  109 are more accurate in differentiating normal from deformed vertebrae than X-ray absorptiometry [40] , particularly in the upper thoracic vertebrae. Lateral X-ray absorptiometry is not an appropriate substitute for radiography in clinical practice in the workup of symptomatic back pain or in other situations in which the presence or absence of a VF needs to be firmly established.
Fractures are the only known clinically relevant consequence of OP. VFs, the most common osteoporotic fractures, are common when searched for systematically and are directly related to low BMD [23, 24] . However, 40% of our RA patients with VFs had osteopenia by WHO criteria, who otherwise may not have been identified as being at greater fracture risk, were found to have unappreciated VFs. It is well known in postmenopausal women that about half of the fractures occur in patients without densitometric OP and that factors other than BMD may play a role [32] . Given the increased risk of vertebral and hip fractures in RA, the early detection of VFs may be particularly important in those who do not have OP by BMD criteria [4, 68] . This can lead to further investigation and appropriate therapy that decreases the risk of future fractures. Unfortunately these clinical markers of established OP often go undiagnosed [33] .
With the exception of older age, female gender and hypercholesterolaemia, which were more common in RA subjects with VFs, the distribution of the other traditional risk factors was similar among those with and without VFs. Our results are in contrast to other reports of fractures in RA, which have shown an equal prevalence of OP and fractures in both genders, those with lower BMI and glucocorticoid users [23, 24, 3436] . However, other studies have demonstrated that the diagnosis of RA is related to the presence of vertebral deformities independent of BMD and glucocorticoid use [22] . Even prospectively, a study conducted in 255 RA patients failed to demonstrate a link between incident VFs and baseline or follow-up use of glucocorticoids [21] . Although the reasons for this are unclear, it is probably related to chronic systemic inflammation, which is consistently associated with bone loss and low BMD [37] .
Previous authors have reported that a longer duration of RA disease did not correlate with the occurrence of fractures [34] . However, it is well established that individuals with the highest concentrations of circulating inflammatory markers are at greatest risk for periarticular as well as systemic bone resorption [37] . Elevated CRP and ACPA levels are significant independent risk factors for osteoporotic fracture in RA populations [30, 38] . In our study we found longer disease duration, elevated markers of inflammation and the presence of ACPA were all independently associated with the presence of VFs after adjustment for traditional risk factors. Therefore the disease-related measurements in RA patients should be taken into account when making the decision whether a DXA should be performed in the assessment of an individual's fracture risk in the setting of RA. However, the extent to which BMD reduction can be directly translated into a risk of fracture in RA patients remains unanswered.
Both clinical and occult VFs are associated with important health consequences [35] . Incident or prevalent VFs are a major risk factor for further fracturing and are an indicator of excess morbidity and mortality [17] . Only 2030% of VFs are recognized clinically [39] , the rest are discovered incidentally on spine radiographs, considered the gold standard for VF detection. Spine X-rays have not been recommended as a component of risk assessment because of the cost, radiation exposure and the fact that the X-ray would require an additional procedure in addition to BMD testing. VFA imaging makes it possible to screen for VFs at the same time as BMD, with reported sensitivities comparable to those of conventional X-ray [19, 40] . This enables earlier detection of high-risk patients at no additional cost or radiation exposure, and minimal additional time [41] , potentially helping clinicians identify patients who might benefit from treatment but who would not be considered for treatment based on current BMD standards alone. Therefore we feel it is necessary to increase awareness of VFs among physicians who deal with RA patients.
Our study has important strengths, including the use of standardized and reproducible validated criteria to identify RA subjects, a large cohort of RA patients representative of patients under long-term follow-up, comprehensive assessment of RA disease-related parameters, the availability of DXA images and blinded assessment for VFs by two musculoskeletal radiologists.
There are also some limitations to this study. First, not all our patients were included in the study because of their age, RA classification or missing clinical data. We did not look at VFs in patients <40 years of age and there may be some censoring by the nature of our study design. While VFs can occur in younger patients, the majority of events occur in, and have been studied in, RA patients 540 years of age [48] . Furthermore, fracture risk is generally lower in these groups. We did not obtain standard spine radiographs to compare with lateral VFA images or to confirm deformities detected on VFA. It is probable that a minority of the apparent deformities, especially those that were grade 1, would not have appeared deformed on standard VFA images. Furthermore, VFA technology is not an appropriate substitute for radiography in clinical practice in the workup of symptomatic back pain or in other situations in which the presence or absence of a VF needs to be firmly established. Although this study was not designed to address a potential role of DMARDs, including TNF-a inhibitors, in the risk of osteoporotic fracture among RA patients, there is some evidence suggesting a beneficial effect of such drugs on bone loss [42] .
Conclusions
VFs were found in 13% of women and men with RA. Longer duration and severity of RA disease were independent risk factors for fractures in our study. These results, taken together with the association between VF and disease-related measurements, give clues to which patients should be referred for DXA VFA measurements. The results are also of importance in health care planning www.rheumatology.oxfordjournals.org for patients with RA. Early intervention to prevent secondary OP is important to avoid fractures and maintain quality of life in patients with RA.
Rheumatology key messages
. Vertebral fracture assessment technology enables earlier detection of vertebral fractures in RA patients without additional tests. . Longer duration and severity of RA were independent risk factors for vertebral fractures in our study. 
